33 results
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
, vendor, consultant, customer or other comparable transactions occurring after the date of this Agreement which are not issued for capital raising
424B5
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Prospectus supplement for primary offering
4:49pm
to the customer a standardized risk disclosure document containing specified information and to obtain from the customer a signed and date acknowledgment
424B5
0jm0c5
17 May 23
Prospectus supplement for primary offering
4:25pm
PRE 14A
7yfxtteqf8qw 2saz3n
17 Apr 23
Preliminary proxy
4:05pm
424B5
b3t27 soyz1s5
25 Jul 22
Prospectus supplement for primary offering
4:26pm
DEF 14A
39x41
25 Apr 22
Definitive proxy
4:06pm
10-K
agwyx9y73jmzl8f
16 Mar 22
Annual report
4:05pm
10-Q
26ogwi0jz81x
13 Aug 21
Quarterly report
4:06pm
424B4
tthmzndwu5k4rwabyl2
28 Jun 21
Prospectus supplement with pricing info
6:02am